Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Gilead Sciences, in partnership with the Global Fund, plans to supply a long-acting HIV prevention drug to low-income ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...

To this day, the UN estimates that one person dies from AIDs every single minute - despite the fact that effective treatement ...

In the mid-nineties, a friend of mine told me that he lost 30 friends and acquaintances to HIV/AIDS in just one week. It was a miracle that he was still alive. Although cases have decreased ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

The AIDS/LifeCycle, a 545-mile bike ride from San Francisco’s Cow Palace to Los Angeles, concluded its final event this year, ...